Literature DB >> 24682510

Desensitization protocol should not be used in acute lymphoblastic leukemia patients with silent inactivation of PEGasparaginase.

Wing H Tong1, Rob Pieters2, Wim J E Tissing3, Inge M van der Sluis4.   

Abstract

Entities:  

Keywords:  PEGasparaginase; acute lymphoblastic leukemia; desensitization protocol; silent inactivation

Mesh：

Substances：

Year:  2014        PMID： 24682510      PMCID： PMC4077093          DOI： 10.3324/haematol.2013.099663

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  11 in total

1.  A desensitization protocol in children with L-asparaginase hypersensitivity.

Authors:  Sinan Akbayram; Murat Doğan; Cihangir Akgün; Hüseyin Caksen; Ahmet Faik Oner
Journal:  J Pediatr Hematol Oncol       Date:  2010-07       Impact factor: 1.289

2.  Rapid desensitization for L-asparaginase hypersensitivity.

Authors:  M Bonno; H Kawasaki; H Hori; M Umemoto; Y Komada; M Sakurai
Journal:  J Allergy Clin Immunol       Date:  1998-04       Impact factor: 10.793

3.  Anti-Escherichia coli asparaginase antibody levels determine the activity of second-line treatment with pegylated E coli asparaginase: a retrospective analysis within the ALL-BFM trials.

Authors:  Andrea Willer; Joachim Gerss; Thorsten König; Dieter Franke; Hans-Jürgen Kühnel; Günter Henze; Arendt von Stackelberg; Anja Möricke; Martin Schrappe; Joachim Boos; Claudia Lanvers-Kaminsky
Journal:  Blood       Date:  2011-09-22       Impact factor: 22.113

4.  A prospective study on drug monitoring of PEGasparaginase and Erwinia asparaginase and asparaginase antibodies in pediatric acute lymphoblastic leukemia.

Authors:  Wing H Tong; Rob Pieters; Gertjan J L Kaspers; D Maroeska W M te Loo; Marc B Bierings; Cor van den Bos; Wouter J W Kollen; Wim C J Hop; Claudia Lanvers-Kaminsky; Mary V Relling; Wim J E Tissing; Inge M van der Sluis
Journal:  Blood       Date:  2014-01-21       Impact factor: 22.113

5.  Silent hypersensitivity to Escherichia coli asparaginase in children with acute lymphoblastic leukemia.

Authors:  Marion Strullu; Nadège Corradini; Marie Audrain; Jean-Luc Orsonneau; Daniel Bouige; Patrick Thomare; Claudine Vermot-Desroches; Adeline Mansuy; Arnaud Legrand; Jean-Christophe Rozé; Mohamad Mohty; Françoise Méchinaud
Journal:  Leuk Lymphoma       Date:  2010-08

Review 6.  Immunologic changes associated with allergen immunotherapy.

Authors:  S R Durham; S J Till
Journal:  J Allergy Clin Immunol       Date:  1998-08       Impact factor: 10.793

7.  Asparaginase antibody and asparaginase activity in children with higher-risk acute lymphoblastic leukemia: Children's Cancer Group Study CCG-1961.

Authors:  Eduard H Panosyan; Nita L Seibel; Sagrario Martin-Aragon; Paul S Gaynon; Ioannis A Avramis; Harland Sather; Janet Franklin; James Nachman; Lawrence J Ettinger; Mei La; Peter Steinherz; Lewis J Cohen; Stuart E Siegel; Vassilios I Avramis
Journal:  J Pediatr Hematol Oncol       Date:  2004-04       Impact factor: 1.289

8.  The cross-reactivity of anti-asparaginase antibodies against different L-asparaginase preparations.

Authors:  Beata Zalewska-Szewczyk; Agnieszka Gach; Krystyna Wyka; Jerzy Bodalski; Wojciech Młynarski
Journal:  Clin Exp Med       Date:  2009-01-30       Impact factor: 3.984

9.  Postinduction dexamethasone and individualized dosing of Escherichia Coli L-asparaginase each improve outcome of children and adolescents with newly diagnosed acute lymphoblastic leukemia: results from a randomized study--Dana-Farber Cancer Institute ALL Consortium Protocol 00-01.

Authors:  Lynda M Vrooman; Kristen E Stevenson; Jeffrey G Supko; Jane O'Brien; Suzanne E Dahlberg; Barbara L Asselin; Uma H Athale; Luis A Clavell; Kara M Kelly; Jeffery L Kutok; Caroline Laverdière; Steven E Lipshultz; Bruno Michon; Marshall Schorin; Mary V Relling; Harvey J Cohen; Donna S Neuberg; Stephen E Sallan; Lewis B Silverman
Journal:  J Clin Oncol       Date:  2013-01-28       Impact factor: 44.544

10.  Monitoring of anti-L-asparaginase antibody and L-asparaginase activity levels in a pediatric patient with acute lymphoblastic leukemia and hypersensitivity to native Escherichia coli L-asparaginase during desensitization courses.

Authors:  Yuta Kawahara; Akira Morimoto; Tomomi Hayase; Yoshifumi Kashii; Tokiko Fukuda; Mariko Y Momoi
Journal:  J Pediatr Hematol Oncol       Date:  2014-03       Impact factor: 1.289
View more
  2 in total

1.  Comment on Ammonia level as a proxy of asparaginase inactivation in children: A strategy for classification of infusion reactions.

Authors:  Wing H Tong
Journal:  J Oncol Pharm Pract       Date:  2021-04-13       Impact factor: 1.809

2.  Retrospective cohort study monitoring PEG-asparaginase activity in acute lymphoblastic leukemia patients with and without premedication.

Authors:  Michael Losasso; Bruce Bostrom; Yoav Messinger
Journal:  F1000Res       Date:  2019-07-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.